RBR-58ftdj
Recruiting
未知
Evaluation of the Effectiveness of an Oral Antiseptic in Improving the Clinical Status, Decreasing Viral Load and Substantivity in Patients with SARS-CoV-2
niversidade de São Paulo0 sitesOctober 28, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversidade de São Paulo
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Volunteer patients; age between 18 to 80 years; both genders; admitted to the State Hospital of Bauru / São Paulo; infected with SARS\-CoV\-2; infection in mild or moderate condition
Exclusion Criteria
- •Patients who are not able to perform daily mouthwash / gargle; refuse to participate in the research; those admitted to the ICU of the State Hospital of Bauru / São Paulo; do not present the age of the age group determined in the inclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Determination of the effectiveness of a mouthwash and nasal spray in clinical improvement, decrease in the number of viruses and their prolonged action in patients with Covid-19viral loadcoronavirus infectionsC01.925.782.600.550.200RBR-8tygcz7niversidade Estadual de Londrina
Not yet recruiting
Not Applicable
The observational study on efficacy of oral anticoagulants for cognitive dysfunctions of the patients after cerebral infarction in super-aged societynon-valvular atrial fibrillation (NVAF)JPRN-UMIN000026912Okayama University Hospital, Department of Neurology160
Completed
Not Applicable
Effect of treatment with oral antibiotics at discharge rates of anal fistulaIRCT201311049936N7Vice –Chancellor of Shiraz University of Medical Sciences, Shiraz, Iran300
Recruiting
Phase 3
Evaluation of the effect of the oral solution including six herbal extracts in the treatment of urolithiasisIRCT20150721023282N4Esfahan University of Medical Sciences116
Completed
Phase 4
The evaluation of the efficacy and safety of oral fingolimod in relapsing remitting multiple sclerosismultiple sclerosis.Disseminated Multiple SclerosisIRCT201406018323N10Vice-chancellor for research, Kermanshah University of Medical Sciences60